News
NAII
3.450
-1.15%
-0.040
Weekly Report: what happened at NAII last week (1124-1128)?
Weekly Report · 4d ago
Weekly Report: what happened at NAII last week (1117-1121)?
Weekly Report · 11/24 10:08
Weekly Report: what happened at NAII last week (1110-1114)?
Weekly Report · 11/17 10:08
Natural Alternatives GAAP EPS of -$0.05, revenue of $37.73M
Seeking Alpha · 11/12 22:30
Natural Alternatives Q1 net loss narrows
Reuters · 11/12 21:53
Natural Alternatives Intl Q1 EPS $(0.05) Up From $(0.33) YoY, Sales $37.730M Up From $33.150M YoY
Benzinga · 11/12 21:50
NAI Reports Q1 Net Loss of $0.3 Million on Sales of $37.7 Million
Reuters · 11/12 21:44
NATURAL ALTERNATIVES INTERNATIONAL, INC. ANNOUNCES 2026 Q1 RESULTS
Reuters · 11/12 21:44
*Natural Alternatives 1Q Loss/Shr 5c >NAII
Dow Jones · 11/12 21:44
*Natural Alternatives 1Q Loss $291,000 >NAII
Dow Jones · 11/12 21:44
Press Release: Natural Alternatives International, Inc. Announces 2026 Q1 Results
Dow Jones · 11/12 21:44
*Natural Alternatives 1Q Sales $37.7M >NAII
Dow Jones · 11/12 21:44
Natural Alternatives: Fiscal Q1 Earnings Snapshot
Barchart · 11/12 15:52
Natural Alternatives International, Inc. Announces 2026 Q1 Results
Barchart · 11/12 15:44
Weekly Report: what happened at NAII last week (1103-1107)?
Weekly Report · 11/10 10:06
Weekly Report: what happened at NAII last week (1027-1031)?
Weekly Report · 11/03 10:07
Zacks Initiates Coverage of NAII With Neutral Recommendation
NASDAQ · 10/27 15:04
Weekly Report: what happened at NAII last week (1020-1024)?
Weekly Report · 10/27 10:09
NAI - Natural Alternatives International Inc. Announces Date for Upcoming Annual Meeting of Stockholders
Reuters · 10/23 20:17
Weekly Report: what happened at NAII last week (1013-1017)?
Weekly Report · 10/20 10:06
More
Webull provides a variety of real-time NAII stock news. You can receive the latest news about Naturl Alt Intl through multiple platforms. This information may help you make smarter investment decisions.
About NAII
Natural Alternatives International, Inc. is a formulator, manufacturer and marketer of nutritional supplements. Its primary business activity is to provide private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbs, and other nutritional supplements, as well as other health care products, to consumers both within and outside the United States. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer ecommerce channels, and retail stores. It manufactures products in a variety of forms, including capsules, tablets, chewable wafers, and powders to accommodate a variety of its customer’s preferences. It also seeks to commercialize its patent and trademarks through the direct distribution and sale of CarnoSyn, SR CarnoSyn, TriBsyn, new contract manufacturing opportunities, and various license, royalty, and similar arrangements.